Zelgen(SH:688266) Xin Lang Cai Jing·2025-11-26 02:13Group 1 - The core point of the news is that Zai Lab's stock price increased by 5.47%, reaching 113.52 CNY per share, with a total market capitalization of 30.05 billion CNY [1] - Zai Lab, established on March 18, 2009, is located in Kunshan, Jiangsu Province, and was listed on January 23, 2020. The company focuses on the research, production, and sales of chemical and biological new drugs [1] - The main revenue composition of Zai Lab is 99.97% from pharmaceuticals, with minimal contributions from intermediates and asset leasing [1] Group 2 - According to data, a fund under Bank of China has Zai Lab as one of its top ten holdings, specifically the Bank of China Healthcare Mixed A Fund, which increased its holdings by 16,000 shares in the third quarter [2] - The Bank of China Healthcare Mixed A Fund has a current holding of 295,400 shares, representing 4.47% of the fund's net value, and is the eighth largest holding [2] - The fund has achieved a year-to-date return of 70.59%, ranking 191 out of 8,134 in its category, and a one-year return of 64.23%, ranking 306 out of 8,056 [2]